Overview
Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides
Status:
Completed
Completed
Trial end date:
2008-02-01
2008-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose is to investigate the effect of oral doses of SLx-4090 over 14 days on subjects with high triglycerides.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Kadmon Corporation, LLC
Criteria
Inclusion Criteria:- Male or female subjects with high triglyceride levels
- Male or female subjects between age 18 and 65 years, inclusive
Exclusion Criteria:
- History of drug abuse
- Any prescribed or over the counter medication taken within 2 weeks prior to
administration of study drug or within 6 times the elimination half-life
- Blood donation of more than 500ml blood in the previous 3 months
- Any confirmed significant allergic reaction against any drug or multiple allergies